The Silent Squeeze: Thousands of Medicare Beneficiaries Lose Crucial Drug Coverage Over Small, Unnoticed Premium Hikes

The crisp Minnesota air is a welcome relief for Jude Pare and his partner, Diane Tix, after their annual winter sojourn in Arizona. But their return home in April was met with a stark and costly reality: Jude’s Medicare prescription drug coverage had been terminated due to three months of unpaid premiums totaling a mere $28.80. This seemingly minor oversight has plunged the 77-year-old into a precarious situation, leaving him without coverage for a vital blood-thinning medication until at least 2027, a consequence of a widespread issue affecting tens of thousands of Medicare beneficiaries enrolled in Wellcare’s Value Script plan.

This unfolding crisis highlights a critical vulnerability within Medicare’s Part D program, where seemingly insignificant premium increases on zero-premium plans can lead to devastating coverage gaps for individuals who may not be fully aware of the changes. Pare’s experience, while dramatic due to the life-sustaining nature of his medication, is far from isolated. A KFF Health News analysis of drug plan data indicates that thousands more individuals across 32 states and Washington D.C. could face similar predicaments in the coming years if premiums on their current zero-premium plans rise and they fail to notice. The looming unveiling of 2027 plan premiums in September carries the potential for a repeat scenario on a larger scale.

The ramifications of losing prescription drug coverage are dire, particularly for Medicare beneficiaries. The Centers for Disease Control and Prevention reports that nearly 90% of Medicare recipients take at least one prescription medication, and almost half manage four or more chronic health conditions. For individuals like Pare, who relies on Xarelto, a blood thinner essential for preventing strokes, blood clots, and pulmonary embolism, the absence of coverage can have life-threatening consequences. A 90-day supply of Xarelto, even with a discount coupon from GoodRx, can cost around $1,800, a prohibitive sum for many.

A System Designed for Competition, Prone to Oversight Gaps

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 introduced prescription drug coverage to Medicare, but with a crucial caveat: it is administered by private insurance companies. This competitive landscape, designed to offer beneficiaries a variety of choices, has led to aggressive marketing strategies, with some insurers, like Wellcare, offering plans with zero monthly premiums to attract a large customer base. Wellcare’s Value Script plan, for instance, has become the bestselling stand-alone prescription drug plan in Medicare, boasting nearly 6 million members nationwide.

However, this model inadvertently creates blind spots. The complexity of Medicare plan offerings, coupled with the infrequent nature of premium changes for those on zero-premium plans, can lead to beneficiaries missing critical notifications. The process of Medicare plan enrollment and disenrollment is governed by specific rules. Typically, after a two-month grace period for unpaid premiums, Medicare drug plans can terminate coverage. Wellcare extended this to three months for its Value Script members, but for many, this extension was not enough to rectify the oversight.

The Unfolding Crisis: Disenrollment and Its Aftermath

Sources indicate that Wellcare terminated coverage for approximately 140,000 Value Script beneficiaries in April. While about 40,000 of these individuals may be eligible for immediate re-enrollment due to low incomes and participation in Medicare’s "Extra Help" program, the remaining 100,000 face a significant hurdle. They are now barred from enrolling in a new plan until the fall open enrollment period for coverage beginning in January of the following year. This means a potential gap of nearly nine months without crucial medication access.

State insurance officials have corroborated these disenrollment figures. Nevada’s Insurance Commissioner, Ned Gaines, who chairs the National Association of Insurance Commissioners’ senior issues task force, alongside Rebecca Gouty, director of West Virginia’s State Health Insurance Assistance Program (SHIP), and Tim Smolen, director of Washington state’s Statewide Health Insurance Benefits Advisors, have all reported similar numbers. These SHIP programs, federally funded, provide impartial assistance to Medicare beneficiaries.

Official Responses and Conflicting Narratives

The Centers for Medicare & Medicaid Services (CMS), which oversees Medicare drug plans, has declined to provide specific disenrollment figures for Wellcare’s Value Script plan, citing a policy against releasing plan-specific or state-level data related to premium non-payment. Christopher Krepich, a CMS spokesperson, stated that the agency does not publicly share such information.

Centene Corp., Wellcare’s parent company, also declined to release disenrollment numbers. Sarah Baiocchi, senior vice president for specialty and prescription drug plans at Centene, acknowledged that "some members in our Value Script plan experienced a premium for the first time, or for the first time in several years." She maintained that all Value Script members received a CMS-required annual notice of changes in September before the premium increases took effect. Baiocchi also stated that the company informed members about these changes through various channels, including phone calls, text messages, mail, and email.

However, the effectiveness of these communication methods is being called into question. A version of the annual notice of changes sent to members in two states and Washington D.C. is a lengthy 21-page document, with the new premium information buried on pages 3 and 8. For individuals who have grown accustomed to a zero-dollar premium, such a document may not trigger immediate alarm, especially if they are not actively monitoring their mail or are inundated with marketing materials.

The Peril of a Late-Enrollment Penalty

The consequences of this coverage gap extend beyond immediate medication needs. Individuals who lose coverage due to non-payment and go without prescription drug coverage for at least 63 days are subject to a permanent late-enrollment penalty. This penalty, assessed annually, increases the cost of their Medicare Part D plan for the rest of their lives. This punitive measure, intended to encourage continuous enrollment, disproportionately affects those who have inadvertently fallen through the cracks of the system.

Wayne Bennett, a 74-year-old resident of Durham, North Carolina, found himself in a similar predicament. He discovered in May that his Wellcare Value Script plan had been canceled due to his failure to pay his $3.60 monthly premium. Bennett takes nine prescription drugs for various health conditions, including blood pressure and glaucoma. While he managed to fill most of his prescriptions before losing coverage, he now faces uncertainty about the cost of his remaining medications. He expressed frustration, stating, "Medicare should be doing something about this so that we can go ahead and get coverage now."

The Social Security Deduction Dilemma

A key factor contributing to the widespread non-payment appears to be a misunderstanding surrounding automatic premium deductions from Social Security benefits. Many Medicare beneficiaries arrange for their monthly drug plan premiums to be automatically deducted from their Social Security checks. However, when a plan’s premium shifts from zero to a positive amount, this automatic deduction process may not automatically continue.

Rebecca Gouty, director of West Virginia’s SHIP program, explained, "They didn’t realize that when the plan was a zero premium in 2025, that stopped the Social Security premium deduction and they would have had to reelect it for 2026." This means that beneficiaries who believed their premiums were still being automatically paid might have been unaware that they needed to re-establish this payment method or set up an alternative plan.

Centene’s Baiocchi pointed to the Social Security Administration as a primary cause for this issue, stating, "We believe this was a key driver of non-payment disenrollments and subsequent complaints." However, spokespeople for the Social Security Administration deferred questions to CMS.

The Broader Implications for Medicare Beneficiaries

The current situation raises serious questions about the adequacy of communication and the fairness of the system for vulnerable Medicare beneficiaries. Gina Upchurch, executive director of Senior PharmAssist, a Durham-based nonprofit that assists Medicare beneficiaries, noted that older adults are frequently advised to be cautious of unsolicited communications, making them more susceptible to dismissing important notifications as scams.

"They are constantly bombarded by people selling them something that’s illegitimate or trying to scam them," Upchurch said. "Since Value Script members such as Bennett continued to get their prescriptions filled during the payment grace period, why wouldn’t they think this was a scam?"

The inability for individuals like Bennett and Pare to re-enroll or join another plan until the open enrollment period, unless they qualify for a special enrollment period, exacerbates the problem. Special enrollment periods are typically granted for specific life events such as moving out of a plan’s service area, experiencing a natural disaster, or receiving assistance from state pharmaceutical programs. While some exceptions exist, such as enrolling in a five-star rated plan (though none are generally available to the public), they offer limited recourse for the vast majority affected.

The crisis underscores the need for a more robust and transparent communication strategy from both insurance providers and Medicare itself. As premiums for prescription drug plans continue to be unveiled, the potential for similar widespread disenrollments remains a significant concern. Ensuring that beneficiaries, particularly those on fixed incomes and with limited digital literacy, are fully informed about premium changes and the consequences of non-payment is paramount to protecting their health and financial well-being. The silent squeeze of unnoticed premium hikes is a stark reminder of the critical need for vigilance and clearer communication within the complex landscape of Medicare.